News
-
-
-
PRESS RELEASE
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
ONWARD® Medical raises EUR 50 million with strategic investment from Ottobock SE & Co. KGaA, extending cash runway. Ottobock acquires c.10% share capital, initiating collaboration for spinal cord injury therapies -
-
-
PRESS RELEASE
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA
ONWARD Medical launches capital increase of c. EUR 40 million with EUR 22.5 million cornerstone investment from Ottobock SE & Co. KGaA, aiming to develop spinal cord stimulation therapies for spinal cord injury patients -
-
-
PRESS RELEASE
ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec
ONWARD Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d'interface cerveau machine WIMAGINE de Clinatec, visant à restaurer les mouvements guidés par la pensée après une paralysie
